1. Home
  2. CORT vs MMS Comparison

CORT vs MMS Comparison

Compare CORT & MMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$46.21

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Logo Maximus Inc.

MMS

Maximus Inc.

HOLD

Current Price

$65.56

Market Cap

3.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CORT
MMS
Founded
1998
1975
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.6B
IPO Year
2001
1997

Fundamental Metrics

Financial Performance
Metric
CORT
MMS
Price
$46.21
$65.56
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$96.50
N/A
AVG Volume (30 Days)
1.2M
530.7K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
2.01%
EPS Growth
N/A
10.42
EPS
0.82
1.70
Revenue
$761,407,000.00
$2,392,236,000.00
Revenue This Year
$26.08
$0.44
Revenue Next Year
$26.98
$5.15
P/E Ratio
$54.66
$38.56
Revenue Growth
12.79
N/A
52 Week Low
$28.66
$60.75
52 Week High
$91.00
$100.00

Technical Indicators

Market Signals
Indicator
CORT
MMS
Relative Strength Index (RSI) 65.13 38.45
Support Level $32.95 $60.75
Resistance Level $47.06 $70.82
Average True Range (ATR) 1.70 2.03
MACD 0.21 0.32
Stochastic Oscillator 88.37 29.60

Price Performance

Historical Comparison
CORT
MMS

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About MMS Maximus Inc.

Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

Share on Social Networks: